PEBC - Programa de Epigenética y Biología del Cáncer 
     
Historical
 
  <
  NEWS PEBC 
 

22/11/2016
Manel Esteller, Josep Baselga and Joan Massagué receive the XXVIII Catalonia International Prize from President Puigdemont
 

10/05/2016
Catalonia's Parliament awards its medal of honor to Dr. Manel Esteller
 

12/02/16
Manel Esteller receives the National Research Prize 2015
 
 
 

 

films

PEBC update

Aseica

 

 

The Bellvitge Institute for Biomedical Research (IDIBELL) is a research foundation set up on 16th June 2004 as a separate legal entity resulting from a change in name of the former August Pi i Sunyer (FAPS) Foundation, set up in 1988. IDIBELL has scientific cooperation agreements with the following institutions/centres:

- University of Barcelona (UB) and its science park
- Bellvitge University Hospital (HUB)

- Catalan Institute of Oncology (ICO)

- Institute for Imaging Diagnosis (IDI)

- Transfusion Centre and Tissue Bank (CTBT)

It is a great pleasure to announce the launching in 2008 of a new research program devoted to basic research within IDIBELL, The Cancer Epigenetics and Biology Program (PEBC).

.>> more info

  LAST PUBLICATIONS  
 

PNAS, Proceedings of the National Academy of Sciences - Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer >>

 

Cancer Research - RANK Signaling Blockade Reduces Breast Cancer Recurrence by Inducing Tumor Cell Differentiation >>

 

The Lancet Oncology - Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis >>

 

 

 

 

 

 

lectures-2011

ICC

 

 

 

 

 
Generalitat de Catalunya Institut d'Investigacio Biomedica de Bellvitge ICREA Sixth Framework Programme Seventh Framework Programme ERC Ministerio de Sanidad y Consumo Ministerio de Educación y Ciencia
 
 

© 2008® | PEBC | Todos los derechos reservados |  WEBMAIL  |  INTRANET  |  FTP